نتایج جستجو برای: factor eight inhibitor bypassing activity

تعداد نتایج: 2125544  

Objective(s):Spinal cord injury (SCI) often causes serious and irreversible neurological deficit leading to disability or impairment of normal physical activity. Atomoxetine, a selective norepinephrine transporter (NET) inhibitor has gained much attention in the field of the neurodevelopmental disorder, but its effect on SCI has not been evaluated. The present study has been undertaken to inves...

Journal: :The Biochemical journal 2012
Susan A Maroney Paul E Ellery Jeremy P Wood Josephine P Ferrel Catherine E Bonesho Alan E Mast

TFPI (tissue factor pathway inhibitor) is an anticoagulant protein that prevents intravascular coagulation through inhibition of fXa (Factor Xa) and the TF (tissue factor)-fVIIa (Factor VIIa) complex. Localization of TFPI within caveolae enhances its anticoagulant activity. To define further how caveolae contribute to TFPI anticoagulant activity, CHO (Chinese-hamster ovary) cells were co-transf...

Journal: :Thrombosis and haemostasis 1999
M Mukherjee V V Kakkar

The effect of a basic synthetic peptide, representing the C-terminal region of tissue factor pathway inhibitor (TFPI - Lys254 - Met276), as well as that of the whole protein, on the activity of lipoprotein lipase (LPL) is described. The activity of bovine LPL was measured by chromogenic assay using a water-soluble chromogenic substrate, p-nitrophenyl butyrate. Five and 10 microM concentrations ...

Journal: :The New England journal of medicine 2015
Deborah M Siegal John T Curnutte Stuart J Connolly Genmin Lu Pamela B Conley Brian L Wiens Vandana S Mathur Janice Castillo Michele D Bronson Janet M Leeds Florie A Mar Alex Gold Mark A Crowther

BACKGROUND Bleeding is a complication of treatment with factor Xa inhibitors, but there are no specific agents for the reversal of the effects of these drugs. Andexanet is designed to reverse the anticoagulant effects of factor Xa inhibitors. METHODS Healthy older volunteers were given 5 mg of apixaban twice daily or 20 mg of rivaroxaban daily. For each factor Xa inhibitor, a two-part randomi...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2007
Masayuki Takeda Tokuzo Arao Hideyuki Yokote Teruo Komatsu Kazuyoshi Yanagihara Hiroki Sasaki Yasuhide Yamada Tomohide Tamura Kazuya Fukuoka Hiroshi Kimura Nagahiro Saijo Kazuto Nishio

PURPOSE AZD2171 is an oral, highly potent, and selective vascular endothelial growth factor signaling inhibitor that inhibits all vascular endothelial growth factor receptor tyrosine kinases. The purpose of this study was to investigate the activity of AZD2171 in gastric cancer. EXPERIMENTAL DESIGN We examined the antitumor effect of AZD2171 on the eight gastric cancer cell lines in vitro and...

2015
Shixuan Zhang Yongming Bao Xiulan Ju Kangjian Li Haiyan Shang Lisha Ha Yuan Qian Liang Zou Xiaodan Sun Jing Li Qianru Wang Qingyu Fan

Cyclin-dependent kinase 1 (CDK1) is the only necessary CDK in cell proliferation and a novel target in the development of anticancer drugs. 8-Hydroxypiperidinemethyl-baicalein (BA-j) is a novel selective CDK1 inhibitor with broad spectrum anti-cancer activity (IC50 12.3 μM) and 2 tumor xenografts. Because of the differential mechanisms controlling redox-states in normal and cancer cells, BA-j c...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید